This discovery was naturally a major one, and unsurprisingly, it was published in the academic journal Nature, making Xingtu Gene Company famous worldwide once again.
Of course, it's one thing if Xingtu Gene Company only wrote one article in the past month and a half.
Xingtu Gene Company publishes two or three papers almost every week, recounting their groundbreaking new discoveries and inventions.
Under such circumstances, Nature, including another academic journal called Biology, appears to outsiders as if it were run by Xingtu Gene Company, taking on the shape of Xingtu Gene Company.
If Xingtu Gene Company's actions had been limited to this, we could have swallowed our anger. However, Xingtu Gene's actions were unusually high-profile.
When they make any new discoveries or inventions in the field of genetics, they often publicize and praise them extensively through major internet portals, Twitter, Weibo, YouTube, TikTok, Bilibili, and other video and news channels such as Today's Hot Topics.
This creates the misconception that all gene technology in the world comes from Xingtu Gene Company, and that all other gene companies or research institutions are garbage.
This naturally displeased researchers and experts in the field of genetics both domestically and internationally, given that the academic journals Nature and Biology only have so many sections.
Each magazine only has about 20 articles per issue, but your Xingtu Gene Company can occupy 2 to 3 articles in each issue with its scientific research results, which greatly increases their pressure and naturally makes them unhappy.
Of course, as much as they were unhappy, those ordinary researchers and related experts and professors ultimately could not influence the two major academic journals, Nature and Biology.
Just because ordinary researchers and relevant experts and professors cannot influence them does not mean that research institutes and big investors cannot.
For example, Church, the director of the Broad Institute at that time, had this influence.
"We cannot allow Xingtu Gene Company to continue its rapid development. If this continues, I'm afraid my Broad Institute will lose its leadership in the field of Gene Editing Technology and be far eliminated."
As he finished speaking, Church already regretted his actions.
They regret selling a series of buyout patents for CRISPR/Cas9 Gene Editing Technology to Xingtu Gene for a mere $230 million.
If the relevant technology patents had not been sold back then, the Broad Institute would not be facing such enormous pressure and challenges now.
It can only be said that the scientific research boosting effect of the Artificial Intelligence Jarvis in the field of gene research is so amazing that it is even greater than the scientific research boosting effect of Supercomputer participating in gene research.
In just one and a half months, Xingtu Gene Company has published more groundbreaking papers in the field of genomics than the Broad Institute could produce in several months!
Although Xingtu Gene Company did not follow the example of their Broad Institute, announcing that their technology patents could be used for free in the field of gene research, and that they would only charge when there was commercial profit.
Even so, the fact that Xingtu Gene Company seemed to have no scientific research bottlenecks and was applying for a large number of technology patents every day made the Broad Institute very sad.
Because if Xingtu Gene Company owns too many core patents, it will hinder the next step of development of Broad Institute.
After all, in any technological path, there will always be some core and key technology patents that cannot be bypassed.
At this time, Xingtu Gene Company frantically achieved scientific research results, registered a large number of patents, and built up a thick technological patent barrier.
This means that if the Broad Institute wants to develop further, it can only find ways to bypass the core technology patents or purchase them to directly skip them and overcome the difficulties.
But under normal circumstances, who would sell their core patents?
In this context, the rapid progress Xingtu Gene Company has made in scientific research and its frantic registration of technology patents to create a patent barrier...
Faced with this situation, Church, the director of the Broad Institute, could not sit still; he had to stop it from happening!
So he started making phone calls, contacting his old friends of many years, ready to show Xingtu Gene what reality is and what underhanded tactics are.
After all, there are quite a few old friends who are unhappy with Xingtu Gene Company or Xingtu Technology. If he takes the initiative to lead the way, there is still a high probability that the matter will be accomplished.
Xingtu Industrial Park, Xingtu Gene Headquarters.
Are these monkeys naturally immune to AIDS?
Lin Feng inspected the progress of the Xingtu Gene Laboratory, accompanied by Professor He Jian.
"Yes, all of these monkeys were injected with the EBT-001 gene therapy agent, which can knock out the SIV Monkey Immunodeficiency Virus."
SIV Monkey Immunodeficiency Virus), also known as African Green Monkey Virus, is a virus that lies dormant in the genes of monkeys, and it has been dormant for as long as 32,000 years.
Although the virus is much less dangerous due to its long incubation period, just like the flu virus, it is less dangerous after such a long incubation period.
However, this does not mean that it will not harm the lives of monkeys and apes, so monkeys can also die from SIV Monkey Immunodeficiency Virus).
The SIV Monkey Immunodeficiency Virus is actually the AIDS in monkeys. If this experiment is successful, it means that it can also solve the problem of AIDS in humans.
After all, both are immunodeficiency viruses. Since immunodeficiency viruses in monkeys and apes can be resolved, there is no reason why human immunodeficiency viruses and AIDS virus cannot be resolved.
Of course, in addition to AIDS, other viruses such as Herpes Simplex Virus and hepatitis B can also be treated in the same way.
By directly knocking out the virus's genes using CRISPR/Cas9 Gene Editing Technology, they can be eliminated from the human body.
Is there any fatal flaw?
Lin Feng asked about Professor He Jian.
"Fatal flaw? There are two fatal flaws. The first fatal flaw is that there is a certain probability of missing the target, which will eventually lead to cancer."
Secondly, the monkeys' immune systems reacted strongly when the EBT-001 gene therapy agent was implanted.
During this period, patients may experience fever, dizziness, high temperature, sweating, and other immune responses. If they cannot withstand these symptoms, they will die suddenly.
At this point, Professor He Jian shook his head with great regret.
Overall, this technology is still in the experimental stage and cannot be applied to humans until it can significantly reduce the immune system response.
After all, if humans were to die suddenly as a result, even if only one out of 100 successful individuals were to die suddenly, the negative impact would still be enormous.
Therefore, this product cannot actually be tested on humans, let alone be sold on the market.
"Is that so? Let's keep up the good work. And of course, remember to share this achievement so that people with AIDS and other viral infections around the world can see a glimmer of hope."
There are 39 million people living with AIDS worldwide. It is a very common disease, and the fact that it is treatable will definitely make them pay close attention to Xingtu Gene.
Therefore, this matter must be widely publicized to provide a large base of supporters for his Fake-to-Real Plan.
"Yes."
Professor He Jian nodded, appearing very supportive of Lin Feng's decision.
Of course, he had to give his full support, after all, this was his research achievement and his research honor.
If this technology can be applied in practice in the future, it will become a savior for the 39 million people living with AIDS worldwide.
Lin Feng smiled at this and then left.
In fact, the scientific research achievements of Xingtu Gene must be widely publicized so that the world knows that Xingtu Gene is a great gene company, a gene company that has repeatedly produced major scientific research results.
Only in this way, when he launches the Gene Enhancement Potion a month later, will people have even the slightest bit of trust in the Gene Enhancement Potion he developed.
After bidding farewell to Professor He Jian, Lin Feng then visited Dr. Gao Caixia's plant Gene Editing Technology laboratory, as well as Dr. Charpentier's laboratory and Dr. Doudna's laboratory.
Dr. Charpentier and Dr. Doudna went their separate ways after joining Xingtu Gene Company.
They are no longer a single experimental group; each has their own research and development direction, and they cooperate as well as compete with each other.
After inspecting the area, Lin Feng arrived at the last large experimental group, which consisted of researchers and experts in the field of genetics who were not particularly well-known.
Their only task is to use the super tool of Artificial Intelligence Jarvis to analyze and discover the role of a certain gene segment in humans and animals.
For example, through big data analysis using the Artificial Intelligence Jarvis, they discovered a gene fragment called ARHGAP11B.
They called this gene fragment the Smart Gene Fragment, and they inserted the human ARHGAP11B gene fragment into mice using CRISPR/Cas9 Gene Editing Technology.
The comparison revealed that this batch of mice had significantly increased brain volume, improved memory flexibility, and enhanced cognitive abilities.
Their anxiety levels were significantly lower than those of normal mice of the same species, and they seemed to have become calmer and more intelligent!